OncLive On Air: Perlmutter Cancer Center medical oncologist uses mobile technology to improve outcomes for underserved people with lung cancer
PPeople with cancer from underserved populations face a number of racial and socioeconomic disparities that contribute to lung cancer incidence and mortality. Vamsidhar Velcheti, MD, director of the thoracic medical oncology program at NYU Langone Health’s Perlmutter Cancer Center and leader of a research team on the SU2C Catalyst for Health Equity in Lung Cancer, speaks with OncLive on the air about the team’s plans to determine whether the use of digital telehealth services and platforms can improve outcomes in black, Hispanic and Asian people with non-small cell lung cancer.
“Patients from underserved minority populations have unique needs that must be addressed, and patient care and referral services are truly unique and must be tailored to the population each of our practices serve. says Dr. Velcheti, also a professor in the Department of Medicine at NYU Grossman School of Medicine. “What we are trying to do here through the Stand Up 2 Cancer Health Equity grant is to combine these patient navigation services and these patient care delivery services with advanced mobile technology-based solutions to ‘to improve a more integrated and efficient care management solution for our patients.’
Listen to Dr. Velcheti’s full interview with OncLive on the air.